These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11097270)

  • 1. Antinociceptive effect of intracerebroventricular administration of cholecystokinin antagonist in nerve-ligated mice.
    Zarrindast MR; Samiee F; Rezayat M
    Pharmacol Toxicol; 2000 Oct; 87(4):169-73. PubMed ID: 11097270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms.
    Rezayat M; Oreizi S; Zarrindast MR
    Gen Pharmacol; 1997 Feb; 28(2):337-40. PubMed ID: 9013214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice.
    Zarrindast MR; Zabihi A; Rezayat M; Rakhshandeh H; Ghazi-Khansari M; Hosseini R
    Pharmacol Biochem Behav; 1997 Sep; 58(1):173-8. PubMed ID: 9264087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha-adrenoceptor agents on imipramine-induced antinociception in nerve-ligated mice.
    Sahebgharani M; Zarrindast M
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):99-104. PubMed ID: 11313154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA mechanisms and antinociception in mice with ligated sciatic nerve.
    Zarrindast MR; Mahmoudi M
    Pharmacol Toxicol; 2001 Aug; 89(2):79-84. PubMed ID: 11555324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists.
    Rastegar H; Homayoun H; Afifi M; Rezayat M; Dehpour AR
    Eur Neuropsychopharmacol; 2002 Apr; 12(2):111-8. PubMed ID: 11872326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin receptor mechanism(s) and morphine tolerance in mice.
    Zarrindast MR; Nikfar S; Rezayat M
    Pharmacol Toxicol; 1999 Jan; 84(1):46-50. PubMed ID: 9974190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and non-ligated mice.
    Zarrindast M; Valizadeh S; Sahebgharani M
    Eur J Pharmacol; 2000 Oct; 407(1-2):65-72. PubMed ID: 11050292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caerulein changes morphine-induced antinociception depending on pretreatment times.
    Zarrindast MR; Rezayat M
    Gen Pharmacol; 1994 Mar; 25(2):311-6. PubMed ID: 8026731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
    Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
    Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caerulein-induced antinociception: interaction with morphine and opioid antagonists in the rat.
    Rattray M; Jordan CC; de Belleroche J
    Neuropeptides; 1989; 14(4):263-8. PubMed ID: 2622523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin and morphine-induced hypothermia.
    Rezayat M; Ravandeh N; Zarrindast MR
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):219-25. PubMed ID: 10208291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
    Tortorici V; Nogueira L; Salas R; Vanegas H
    Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin receptor agonist and antagonists on morphine dependence in mice.
    Zarrindast MR; Malekzadeh A; Rezayat M; Ghazi-Khansari M
    Pharmacol Toxicol; 1995 Dec; 77(6):360-4. PubMed ID: 8835359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of antinociceptive effect of caerulein by benzodiazepine.
    Kubota K; Sun FY; Sugaya K; Sunagane N
    J Pharmacobiodyn; 1986 Apr; 9(4):428-31. PubMed ID: 2874207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
    Suh HW; Kim YH; Choi YS; Song DK
    Peptides; 1995; 16(7):1229-34. PubMed ID: 8545243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
    Holmes BB; Rady JJ; Smith DJ; Fujimoto JM
    Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cholecystokinin receptors in induction of antinociception in hot-plate test.
    Rezayat M; Rahnavard A; Zarrindast MR
    Pharmacol Toxicol; 2000 Aug; 87(2):58-62. PubMed ID: 10989941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.